2635386-55-7
2635386-55-7
Chemical Structure
P19As
- CAS No.: 2635386-55-7
- Formula:C47H51ClF2N12O10
- Molecular Weight:1017.43
InChIKey: LUCAXHCIOIVJQP-LERZKORDSA-N
SMILES: O=C(CCCC1=CN(CCOCCOCCOCCNC2=CC=CC(C(N3C4C(NC(CC4)=O)=O)=O)=C2C3=O)N=N1)N[C@@H]5CCN(C6=NC=C(C(NC7=CC=C(OC(Cl)(F)F)C=C7)=O)C=C6C8=NNC=C8)C5
Biological Activity: P19As is a BCR-ABL PROTAC degrader based on Asciminib (HY-104010), with a DC50 value of approximately 200 nM for the wild-type BCR-ABL protein. P19As can degrade the T315I mutant and exhibits potent anti-proliferative activity in BaF3-BCR-ABL (T315I) cells. P19As can be used for the study of chronic myeloid leukemia and acute lymphoblastic leukemia[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
P19As | P19As is a BCR-ABL PROTAC degrader based on Asciminib (HY-104010), with a DC50 value of approximately 200 nM for the wild-type BCR-ABL protein. P19As can degrade the T315I mutant and exhibits potent anti-proliferative activity in BaF3-BCR-ABL (T315I) cells. P19As can be used for the study of chronic myeloid leukemia and acute lymphoblastic leukemia. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
